Puretech Health Share Price (PRTC)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Puretech Health Plc	LSE:PRTC	London	Ordinary Share	GB00BY2Z0H74	ORD 1P

	Price Change	% Change	Share Price	Shares Traded	Last Trade
	4.00	1.17%	347.00	170,646	16:29:53

Bid Price		Offer Price	High Price	Low Price	Open Price
347.00		348.00	353.00	335.50	336.00

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Pharmaceuticals & Biotechnology	8.61	13.87	1.46	241.6	992

Last Trade Time	Trade Type	Trade Size	Trade Price	Currency
17:06:15	O	71	347.017	GBX

Related Shares
Astrazeneca (AZN), Glaxosmithkline (GSK), Motif Bio (MTFB), Bermele (BERM)

Puretech Health (PRTC) Latest News

Puretech Health News

Date	Time	Source	Headline
16/6/2021	14:23	ALNC	IN BRIEF: PureTech buys remaining 22% stake in Alivio Therapeutics
16/6/2021	12:00	RNSNON	PureTech Health PLC PureTech Acquires Alivio and Oral IL-22 Candidate
02/6/2021	07:00	UKREG	PureTech Health PLC PDMR Notification RSU Vesting
01/6/2021	07:00	UKREG	PureTech Health PLC Total Voting Rights
27/5/2021	18:16	UKREG	PureTech Health PLC Result of AGM
27/5/2021	14:50	RNSNON	PureTech Health PLC PureTech's Gelesis Presents Plenity Data at AACE
26/5/2021	18:03	ALNC	IN BRIEF: PureTech Health's Akili secures USD160 million in financing
26/5/2021	13:05	RNSNON	PureTech Health PLC PureTech's Akili Secures $160M in Financing
25/5/2021	12:00	RNSNON	PureTech Health PLC PRTC Presents at Jefferies Healthcare Conference
12/5/2021	12:00	RNSNON	PureTech Health PLC PureTech Forms IPF Clinical Advisory Board

More Puretech Health News

Puretech Health Investors Puretech Health Takeover Rumours

Puretech Health (PRTC) Share Charts 1 Year Puretech Health Chart
1 Month Puretech Health Chart	Intraday Puretech Health Chart

Puretech Health (PRTC) Discussions and Chat

Puretech Health Forums and Chat

Date	Time	Title	Posts
17/6/2021	15:52	PureTech Health - innovative healthcare	1,211
22/7/2018	21:35	PureTech Health (PRTC) One to Watch Monday	-

Add a New Thread

Puretech Health (PRTC) Most Recent Trades

Trade Time	Trade Price	Trade Size	Trade Value	Trade Type
16:06:15	347.02	71	246.38	O
15:58:32	348.95	525	1,831.99	O
15:58:28	347.95	5,894	20,508.06	O
15:35:00	347.00	42,030	145,844.10	UT
15:29:53	347.00	128	444.16	AT

View all Puretech Health trades in real-time

Puretech Health (PRTC) Top Chat Posts

Date	Subject
22/6/2021 09:20	Puretech Health Daily Update: Puretech Health Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker PRTC. The last closing price for Puretech Health was 343p. Puretech Health Plc has a 4 week average price of 335.50p and a 12 week average price of 335.50p. The 1 year high share price is 446p while the 1 year low share price is currently 232.50p. There are currently 285,898,746 shares in issue and the average daily traded volume is 271,077 shares. The market capitalisation of Puretech Health Plc is £992,068,648.62. Read Full Thread Reply
10/6/2021 12:37	mighunter: Liberum mark Puretech as joint top pick in medical sector this morning (other is Medica MGP), reiterating PRTC buy with PT of 540p. Read Full Thread Follow Reply
26/5/2021 14:38	rambutan2: I assume reason for today's rise: BOSTON, Mass. – May 26, 2021 – Akili Interactive (“Akili” or “Company”), maker of EndeavorRx™, the first and only prescription video game treatment, today announced $160M in combined equity and debt financing. Akili is a pioneer of a new class of medicine and treatments that are not only effective and clinically-validated but that deliver amazing experiences to patients. The Company’s flagship product made history in June 2020 when it received U.S. Food and Drug Administration (FDA) clearance. With the completion of the oversubscribed Series D financing, Akili will continue to push the boundaries of traditional medicine to deliver on the promise of digital therapeutics for patients. The $110M Series D equity financing was led by Neuberger Berman Funds and joined by new investors Polaris Partners; Mirae Assets; Shionogi & Co., Ltd., New Leaf Venture Partners; Dave Baszucki, Founder and CEO of Roblox Corporation; QUAD Investment Management, and Ladera Venture Partners. Existing Akili investors Temasek, Baillie Gifford, JAZZ Venture Partners, Evidity Health Capital, Omidyar Technology Ventures, Fearless Ventures, Amgen Ventures, and M Ventures (the corporate VC fund of Merck KGaA, Darmstadt, Germany) all participated in the financing round. https://investegate.co.uk/puretech-health-plc--prtc-/rns/puretech-s-akili-secures--160m-in-financing/202105261305018060Z/ Read Full Thread Follow Reply
18/3/2021 04:05	rambutan2: Interesting to see where the two US analysts currently covering PRTC stand: 15/01/21: SVB Leerink analyst Thomas J. Smith initiated coverage of PureTech Health with an Outperform rating and $70 price target. Smith says LYT-100, a deuterated form of Pirfenidone, has demonstrated potentially improved PK and safety/tolerability relative to the parent molecule, and is currently being evaluated in Phase 2 trials to treat breast cancer-related lymphedema and post-acute COVID-19 respiratory complications, while the company is also planning to advance LYT-100 in progressive-fibrotic interstitial lung diseases including idiopathic pulmonary fibrosis, where the analyst believes LYT-100 could differentiate on better safety/tolerability, potentially enhanced efficacy, and less frequent dosing that could displace Pirfenidone as backbone standard of care. 10/02/21: Piper Sandler analyst Edward Tenthoff raised the firm's price target on PureTech Health (PRTC) to $76 from $66 and reiterates an Overweight rating on the shares. Puretech sold 1M Karuna Therapeutics (KRTX) shares for $118M and still holds 2.4M shares or about 9% of Karuna, Tenthoff tells investors in a research note. Separately, Vor Biopharma (VOR) completed a successful initial public offering and PureTech retains 3.2M Vor shares, the analyst adds. These two deals account for the target raise. Read Full Thread Follow Reply
12/3/2021 13:51	lendmeafiver: You are absolutely right, zero value attributed to it in the share price at the moment, I believe Peel Hunts recent uplifted target price was partly to reflect the value of the internal pipeline. Read Full Thread Follow Reply
08/2/2021 11:25	volvo: The the doubling action on VOR and the Karuna topping $120 added quite literally added over $100m to Puretech as additional assets....UK market gives it $10m....total VOR plus Karuna $520m, thats insane Vedanta IPO is already eagerly awaiting, more than VOR is/was. Vedanta could see $1 billion added to Puretech's coffers at launch.....or £730m nearly 3/4 the share price, because anyone can see nothing is in the share price yet Read Full Thread Follow Reply
16/11/2020 08:27	volvo: Daphne spells it out at 5 minutes into her Credit Suisse presention last Thursday..... abridged version.... The board of directors can see a clear share price disconnect between our achievements to date and our share price, blames directly the London listing for the SIGNIFICANT discount, then compares the cash of $387m and the 12 pc stake in Karuna $350 as virtually equating to the current share price so everything else for free, 8 founded entities, and the associated royalties and all of the wholly owned pipeline, THEN she says that is why they are listed on the NASDAQ to achieve proper market value Listen to it and sit back and imagine how high the shares will go in the USA. Daphne is beating the drum and rightly so. https://kvgo.com/credit-suisse/puretech-november-2020 Read Full Thread Follow Reply
14/11/2020 19:35	deadly nightshade: excellent thanks volvo roll on monday i can't wait, be good if we can see the back of these ii's then hopefully after the share price will find its true level rather then constant selling by them into any rise that way hindering the share price Read Full Thread Follow Reply
04/6/2020 20:15	lendmeafiver: what the PRTC Share Price? Read Full Thread Follow Reply
10/12/2019 19:19	lendmeafiver: Further good news flow here today and KRTX looking solid, whilst the PRTC share price seems to be all over the place on minimal volume. Read Full Thread Follow Reply
02/5/2019 18:08	lendmeafiver: Agree. Surely given recent progress an ipo or other transaction at Gelesis has to be on the cards, will have a huge impact on the Prtc share price I expect. Read Full Thread Follow Reply

Puretech Health share price data is direct from the London Stock Exchange

Advertise Here

Your Recent History

LSE

PRTC

Puretech H..

Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US

P: V: D:20210622 21:17:07